J Stock Recent News

Jacobs Solutions is a specialty manufacturing company operating across a variety of growth markets. Jacobs works closely with Eli Lilly, the pharmaceutical giant behind diabetes and chronic weight management medications Mounjaro and Zepbound.

Jacobs (J) is set to deliver a master plan and runway design to develop the King Salman International Airport in Riyadh, Saudi Arabia.

Jacobs (J) to enhance DC Streetcar with expanded operations, maintenance and engineering support.

Jacobs (J) develops efficient, integrated solutions and recommends preferred options based on best value, lowest carbon and cost.

Jacobs' (J) first-quarter fiscal 2024 results reflect growth across all lines of business.

Digital & technological solutions and Focus 2023 efforts are likely to have reflected in Jacobs' (J) fiscal Q3 performance. However, higher expenses might have been a headwind.

Jacobs Solutions is expected to see strong revenue growth due to its expertise in digital transformation, which is predicted to grow by 17-20% CAGR over the next seven years. The company's planned split into two entities could increase efficiency and profitability but also carries risks, including potential loss of value if the spinoff efforts are not successful. Despite a debt of $3.4B, the company's financials are considered healthy, with an intrinsic value of $162.86 per share, suggesting it is currently undervalued by around 29%.

Jacobs' (J) Q2 results reflect solid contributions from its businesses. The company also plans to separate its CMS business, resulting in two independent entities.